Evidence map›Paper›PMID 41602303›Full record

ReviewFrontiers in artificial intelligence2025

Beyond mimicry: a framework for evaluating genuine intelligence in artificial systems.

Sarfaraz K Niazi

Abstract readReview
In one paragraph

Review in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sarfaraz K NiaziPharmaceutical Sciences, University of Illinois, Chicago, IL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current AI benchmarks often equate mimicry with genuine intelligence, emphasizing task performance over the underlying cognitive processes that enable human-like understanding. The Machine Perturbational Complexity & Agency Battery (mPCAB) introduces a new, substrate-independent framework that applies neurophysiological methods used initially to assess consciousness in artificial systems. Unlike existing evaluations, it features four key components-perturbational complexity, global workspace assessment, norm internalization, and agency-that link mechanisms with functions. This enables systematic comparisons across digital, neuromorphic, and biological substrates, addressing three research gaps: long-term reasoning with coherent behavior, norm internalization amid distribution shifts, and transformational creativity involving meta-cognitive rule modification. By analyzing theories of consciousness (GNW, IIT, PP, HOT), we identify targets for AI implementation. Our cognitive architecture analysis maps human functions-such as working memory and executive control-to their computational counterparts, providing guiding principles for design. The creativity taxonomy progresses from combinational to transformational, with measurable criteria like changes in conceptual space and the depth of meta-level reasoning. Ethical considerations are integrated into frameworks for monitoring organoid intelligence, reducing bias in creativity, and addressing rights issues. Pilot studies demonstrate mPCAB's feasibility across different substrates and show that its metrics are comparable. This framework moves evaluation away from superficial benchmarks toward mechanism-based assessment, supporting the development of mind-like machines and responsible AI advancements.

Indexed as

agencyartificial intelligencecreativityevaluation frameworksmachine consciousnessneuromorphic computingorganoid intelligenceperturbational complexity

Identifiers

PMID41602303
PMCPMC12832969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.